“Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation”. Journal of Kidney Cancer, vol. 7, no. 1, June 2020, pp. 7-11, https://doi.org/10.15586/jkcvhl.2020.135.